Ocean Biomedical Performance
| OCEAWDelisted Stock | 0.0009 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Ocean Biomedical are completely uncorrelated. Ocean Biomedical right now holds a risk of 0.0%. Please check Ocean Biomedical relative strength index , to decide if Ocean Biomedical will be following its historical price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Ocean Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Ocean Biomedical is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
Ocean |
Ocean Biomedical Relative Risk vs. Return Landscape
If you would invest 0.09 in Ocean Biomedical on November 22, 2025 and sell it today you would earn a total of 0.00 from holding Ocean Biomedical or generate 0.0% return on investment over 90 days. Ocean Biomedical is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Ocean, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Ocean Biomedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ocean Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ocean Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ocean Biomedical is not yet fully synchronised with the market data | |
| Ocean Biomedical has some characteristics of a very speculative penny stock | |
| Ocean Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (9.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ocean Biomedical generates negative cash flow from operations |
Ocean Biomedical Fundamentals Growth
Ocean Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ocean Biomedical, and Ocean Biomedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ocean Pink Sheet performance.
| EBITDA | (957.74 K) | |||
| Total Debt | 16.3 M | |||
| Cash Flow From Operations | (4.18 M) | |||
| Total Asset | 902 K | |||
| Retained Earnings | (205.53 M) | |||
About Ocean Biomedical Performance
Evaluating Ocean Biomedical's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Ocean Biomedical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ocean Biomedical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Ocean Biomedical performance evaluation
Checking the ongoing alerts about Ocean Biomedical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ocean Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ocean Biomedical is not yet fully synchronised with the market data | |
| Ocean Biomedical has some characteristics of a very speculative penny stock | |
| Ocean Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (9.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ocean Biomedical generates negative cash flow from operations |
- Analyzing Ocean Biomedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ocean Biomedical's stock is overvalued or undervalued compared to its peers.
- Examining Ocean Biomedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ocean Biomedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ocean Biomedical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ocean Biomedical's pink sheet. These opinions can provide insight into Ocean Biomedical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Ocean Pink Sheet
If you are still planning to invest in Ocean Biomedical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ocean Biomedical's history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |